Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9594 posts found.

Novo Nordisk appoints ex-Pfizer head

May 10, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novo Nordisk, Pfizer, Robert Clark, regulatory affairs

Robert Clark will be joining Novo Nordisk as vice president, regulatory affairs. Clark will lead Novo Nordisk’s US regulatory team, …
Appointment

Teva appoints new president of R&D

May 9, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Michael Hayden, R&D, Teva

Teva has appointed Dr Michael Hayden as its new president of global R&D and chief scientific officer at the firm’s …
Appointment

GSK raises bid for Human Genome Services

May 9, 2012 Research and Development, Sales and Marketing GSK, Human Genome Services, bid, takeover

The latest round in GlaxoSmithKline’s attempt to take over Human Genome Services has begun with GSK appealing directly to the …
News

Celgene appoints Thomas Moriarty as general counsel

May 9, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Celgene, Moriarty

Celgene has appointed Thomas Moriarty as its new general counsel and corporate secretary. In this position, he will be responsible …
Appointment

Pfizer releases new data for Pristiq

May 9, 2012 Research and Development, Sales and Marketing Effexor, MDD, Pfizer, Pristiq, antidepressant

Pfizer has released positive data for its established antidepressant Pristiq, as it hopes to extend the use of the drug.  …
News

The joy of segmentation

May 8, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing MSI, Michael Craig, marketing, segmentation

We are all different. Different heights, shapes, hair colour and we are not just different physically – what about our …
Feature

Former Novartis man becomes GSK’s new medical director

May 8, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, James Shannon, Novartis

James Shannon has been named GSK’s chief medical officer, and will report to R&D chairman Moncef Slaoui.  He will be …
Appointment
Roche image

Roche abandons Phase III cholesterol drug

May 8, 2012 Medical Communications, Research and Development, Sales and Marketing CETP inhibitor, Roche, cardiovascular, dalcetrapib, phase III failure

Roche has abandoned its Phase III cholesterol treatment dalcetrapib after disappointing results.The manufacturer is ceasing work on the drug, once …
News
GSK picture

GSK signs deal with academics

May 4, 2012 Research and Development, Sales and Marketing Cancer, GSK, PROTAC, Yale, academia

GlaxoSmithKline has forged another link with academia, signing a deal with Yale University to design a potential new class of …
News

GSK appoints two non-executive directors to its Board

May 3, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, Jing Ulrich, Lynn Elsenhans

GlaxoSmithKline has announced that Lynn Elsenhans and Jing Ulrich will join the Board of the Company with effect from 1 …
Appointment

Oxford BioTherapeutics appoints new chief operations officer

May 3, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Oxford Biotherapeutics

Oxford BioTherapeutics (OBT) has appointed Dr Esteban Pombo-Villar as its new chief operations officer (COO). In this position he will …
Appointment

Professional regulation – a DIY job?

May 2, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CPD, GMC, Les Rose, drug discovery, regulation

What would happen if we had no drug regulatory bodies, such as the MHRA and the EMA? Can you imagine …
Feature

Lilly invests in UK research base

May 2, 2012 Research and Development Elil Lilly, Erl Wood, neuroscience

Eli Lilly has officially opened new research facilities at its R&D base in Erl Wood in Surrey.The site near Woking …
News

Targacept cuts workforce

May 1, 2012 Research and Development, Sales and Marketing AstraZeneca, MDD, TC-5214, Targecept

The fall-out from pipeline difficulties has led US biopharma company Targacept to make almost half its workforce redundant. In March …
News

EMA eSubmission Gateway now live

May 1, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing wainwright associates; ectd

Following a successful pilot, the European Medicines Agency (EMA) has announced that its eSubmission Gateway is now live for all …
News
Press release
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026